With respect to cancer aggressiveness and patient prognosis, the presence of CXCL10 and CXCR3 has shown conflicting results depending on the type and stage of the disease (Fulton, 2009; Jacquelot et al., 2018; Li et al., 2015). The gene discussed is CXCR3; the disease is cancer.